Stratec SE (SBS.DE)
EUR 28.25
(-1.91%)
EUR 28.25
(-1.91%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 39.82 Million EUR | -27.61% |
| 2022 | 57.52 Million EUR | -14.95% |
| 2021 | 65.44 Million EUR | 25.35% |
| 2020 | 52.58 Million EUR | 45.49% |
| 2019 | 36.08 Million EUR | 1.39% |
| 2018 | 34.85 Million EUR | -21.3% |
| 2017 | 47.03 Million EUR | 33.64% |
| 2016 | 35.05 Million EUR | 6.06% |
| 2015 | 33.58 Million EUR | 3.06% |
| 2014 | 32.46 Million EUR | 23.89% |
| 2013 | 26.11 Million EUR | 21.38% |
| 2012 | 21.55 Million EUR | -15.54% |
| 2011 | 25.27 Million EUR | 21.19% |
| 2010 | 21.09 Million EUR | 17.96% |
| 2009 | 17.88 Million EUR | 5.26% |
| 2008 | 11.89 Million EUR | -49.6% |
| 2007 | 16.97 Million EUR | -16.03% |
| 2006 | 12.76 Million EUR | 402.06% |
| 2005 | 8.2 Million EUR | 46.11% |
| 2004 | 5.69 Million EUR | 47.03% |
| 2003 | 3.72 Million EUR | 41.24% |
| 2002 | 2.63 Million EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 7.07 Million EUR | -31.94% |
| 2024 Q2 | 10.41 Million EUR | 53.02% |
| 2024 Q1 | 5.77 Million EUR | -51.55% |
| 2023 FY | - EUR | -27.61% |
| 2023 Q1 | 7.18 Million EUR | -26.83% |
| 2023 Q2 | 5.77 Million EUR | -19.67% |
| 2023 Q3 | 13.09 Million EUR | 126.75% |
| 2023 Q4 | 14.88 Million EUR | 13.73% |
| 2022 Q1 | 18.45 Million EUR | 108.53% |
| 2022 Q2 | 9.38 Million EUR | -49.17% |
| 2022 FY | - EUR | -14.95% |
| 2022 Q3 | 20.25 Million EUR | 115.88% |
| 2022 Q4 | 9.82 Million EUR | -51.51% |
| 2021 FY | - EUR | 25.35% |
| 2021 Q3 | 17.39 Million EUR | -18.86% |
| 2021 Q4 | 8.85 Million EUR | -49.1% |
| 2021 Q1 | 18.84 Million EUR | 13.85% |
| 2021 Q2 | 21.43 Million EUR | 13.77% |
| 2020 FY | - EUR | 45.49% |
| 2020 Q3 | 12.28 Million EUR | -15.8% |
| 2020 Q2 | 14.58 Million EUR | 9.67% |
| 2020 Q1 | 13.3 Million EUR | 0.35% |
| 2020 Q4 | 16.54 Million EUR | 34.71% |
| 2019 Q1 | 6.68 Million EUR | -55.83% |
| 2019 FY | - EUR | 1.39% |
| 2019 Q2 | 9.42 Million EUR | 40.93% |
| 2019 Q3 | 8.73 Million EUR | -7.3% |
| 2019 Q4 | 13.25 Million EUR | 51.81% |
| 2018 Q2 | 6.27 Million EUR | 6.4% |
| 2018 Q3 | 9.35 Million EUR | 49.2% |
| 2018 Q4 | 15.13 Million EUR | 61.69% |
| 2018 Q1 | 5.89 Million EUR | -68.52% |
| 2018 FY | - EUR | -21.3% |
| 2017 Q2 | 7.54 Million EUR | -10.91% |
| 2017 FY | - EUR | 33.64% |
| 2017 Q4 | 18.72 Million EUR | 48.63% |
| 2017 Q3 | 12.6 Million EUR | 67.11% |
| 2017 Q1 | 8.46 Million EUR | -45.72% |
| 2016 Q3 | 5.9 Million EUR | 8.93% |
| 2016 Q1 | 4.52 Million EUR | -55.67% |
| 2016 Q2 | 5.42 Million EUR | 19.72% |
| 2016 FY | - EUR | 6.06% |
| 2016 Q4 | 15.59 Million EUR | 163.97% |
| 2015 Q2 | 7.28 Million EUR | 5.32% |
| 2015 Q1 | 6.91 Million EUR | -28.47% |
| 2015 Q3 | 9.17 Million EUR | 25.91% |
| 2015 Q4 | 10.21 Million EUR | 11.42% |
| 2015 FY | - EUR | 3.06% |
| 2014 Q1 | 6.55 Million EUR | -34.96% |
| 2014 Q2 | 7.3 Million EUR | 11.41% |
| 2014 Q4 | 9.66 Million EUR | 8.14% |
| 2014 Q3 | 8.93 Million EUR | 22.37% |
| 2014 FY | - EUR | 23.89% |
| 2013 FY | - EUR | 21.38% |
| 2013 Q2 | 4.9 Million EUR | -7.5% |
| 2013 Q1 | 5.3 Million EUR | 3.92% |
| 2013 Q4 | 10.08 Million EUR | 72.4% |
| 2013 Q3 | 5.84 Million EUR | 19.2% |
| 2012 Q2 | 6.12 Million EUR | 14.95% |
| 2012 Q4 | 5.1 Million EUR | 4.38% |
| 2012 FY | - EUR | -15.54% |
| 2012 Q1 | 5.32 Million EUR | -32.88% |
| 2012 Q3 | 4.89 Million EUR | -20.1% |
| 2011 Q4 | 7.93 Million EUR | 14.81% |
| 2011 Q1 | 4.75 Million EUR | -69.3% |
| 2011 Q3 | 6.9 Million EUR | 14.58% |
| 2011 FY | - EUR | 21.19% |
| 2011 Q2 | 6.03 Million EUR | 26.76% |
| 2010 Q1 | 4.43 Million EUR | -64.27% |
| 2010 FY | - EUR | 17.96% |
| 2010 Q2 | 4.94 Million EUR | 11.62% |
| 2010 Q3 | 5.6 Million EUR | 13.26% |
| 2010 Q4 | 15.49 Million EUR | 176.5% |
| 2009 Q2 | 4.23 Million EUR | 27.31% |
| 2009 Q3 | -2.04 Million EUR | -148.33% |
| 2009 FY | - EUR | 5.26% |
| 2009 Q1 | 3.32 Million EUR | 0.0% |
| 2009 Q4 | 12.4 Million EUR | 706.35% |
| 2008 FY | - EUR | -49.6% |
| 2007 FY | - EUR | -16.03% |
| 2006 FY | - EUR | 402.06% |
| 2005 FY | - EUR | 46.11% |
| 2004 FY | - EUR | 47.03% |
| 2003 FY | - EUR | 41.24% |
| 2002 FY | - EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| aap Implantate AG | -3.43 Million EUR | 1260.286% |
| Drägerwerk AG & Co. KGaA | 318.33 Million EUR | 87.491% |
| Drägerwerk AG & Co. KGaA | 318.33 Million EUR | 87.491% |
| elexxion AG | -860.59 Thousand EUR | 4727.126% |
| Eckert & Ziegler Strahlen- und Medizintechnik AG | 57.48 Million EUR | 30.733% |
| Geratherm Medical AG | 4.18 Million EUR | -851.657% |
| Koninklijke Philips N.V. | 1.04 Billion EUR | 96.175% |
| Siemens Healthineers AG | 4.22 Billion EUR | 99.057% |